đŹ Current Disease Focus:
Task Progress: 0%
đ„ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
đ§Ș Experimental Design
đŹ Clinical Trials
đ Treatment Development
Researchers conducting this study hope to learn about the safety and effect...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2025-01-06
Trial ID
NCT05726292
The goal of this clinical trial is to learn whether letrozole, a hormone th...
Status
Not Yet Recruiting
Location
Cancer Care Hospital and Research Centre Foundation
Start Date
2026-06
Trial ID
NCT07394946
Treatments Being Tested
This study is to measure the extent of tumor shrinkage when Letrozole and Z...
Status
Completed
Location
Novartis Investigative Site
Start Date
2005-09
Trial ID
NCT00247650
Treatments Being Tested
Prognostic factors in locally advanced breast cancer treated with neoadjuva...
Status
Completed
Location
Multiple Locations
Start Date
2006-07
Trial ID
NCT01396655
Treatments Being Tested
A multicenter, prospective, open, randomized cohort, non controlled phase I...
Status
Completed
Location
Jie Ge
Start Date
2023-04-11
Trial ID
NCT06009627
Observational investigation of participants who are given neoadjuvant treat...
Status
Not Yet Recruiting
Location
National Institute of Oncolgy
Start Date
2022-03
Trial ID
NCT05131893
The purpose of this study is to find out whether combining a shorter than s...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2021-10-19
Trial ID
NCT05100472
RATIONALE: Hormones can stimulate the growth of prostate cancer cells. Horm...
Status
Completed
Location
University of Alabama at Birmingham Comprehensive Cancer Center
Start Date
2000-02
Trial ID
NCT00005044
Treatments Being Tested
This is an open-label, multicenter international trial in men and women wit...
Status
Active Not Recruiting
Location
Sainte Catherine - Institut du Cancer Avignon Provence
Start Date
2022-05-03
Trial ID
NCT05296746
Treatments Being Tested
Q3week carboplatin with weekly abraxane and trastuzumab as neoadjuvant ther...
Status
Completed
Location
City of Hope
Start Date
2008-02
Trial ID
NCT00617942
Treatments Being Tested